Keywords
Musculoskeletal triage; physiotherapy; orthopaedic triage, rheumatology triage; predictors of outcome; musculoskeletal pain, healthcare utilisation, cohort study
Clinical specialist physiotherapist-led musculoskeletal triage clinics were introduced nationally in Ireland in 2011 to improve patient care and reduce waiting times for secondary care orthopaedics and rheumatology. Evidence has shown them to be effective in reducing waiting lists, however there are currently no data on longitudinal patient outcomes following attendance at these clinics. The primary aim of this prospective, cohort study is to identify predictors of clinical outcome (pain and function) at 12-months post MSK-triage appointment. Secondary aims are to describe the clinical course of patients attending MSK triage clinics and measure self-reported use of healthcare resources up to 12 months post-MSK-triage appointment. This is a prospective cohort study.
ADvAnced PhysioTherapy in MuSculosKeletal Triage (ADAPT MSK) will recruit a cohort of 252 adults through musculoskeletal triage clinics across five secondary care sites in Ireland. The STrengthening the Reporting of Observational studies in Epidemiology (STROBE) guidelines will be adhered to for future reporting. Adults (≥ 18 years old) attending physiotherapist-led musculoskeletal triage clinics with musculoskeletal pain, who do not require surgical or consultant-led medical care will be considered for participation in this study. Participant demographics, health literacy, healthcare utilisation, and self-report questionnaires on pain, function, musculoskeletal health status, musculoskeletal risk stratification, fear of movement, and psychological distress will be obtained at baseline, with follow-ups at three, six, and 12 months. The primary outcomes are pain intensity and function. Secondary outcomes include musculoskeletal risk stratification status, musculoskeletal health status, healthcare utilisation, and work status. Descriptive statistics will be used to profile the cohort of participants and predictors of outcome will be assessed using multivariable linear regression.
Results will be disseminated via peer-reviewed journal publication and presentation at national and international conferences. Engagement with a public patient involvement (PPI) panel will explore dissemination strategies for public and service user engagement.
Musculoskeletal triage; physiotherapy; orthopaedic triage, rheumatology triage; predictors of outcome; musculoskeletal pain, healthcare utilisation, cohort study
In response to reviewer feedback a number of changes have been made to the protocol.
We have provided clarity on our sample size calculation.
We have revised our primary and secondary aims.
We have revised and further developed our statistical analysis plan in line with revised aims.
We have further developed the introduction and discussion section.
Health literacy has been included in the relevant sections and Table 1.
We have addressed grammatical and terminology concerns throughout the manuscript.
See the authors' detailed response to the review by helen o'leary
See the authors' detailed response to the review by Karin Samsson
Musculoskeletal (MSK) pain, which includes conditions such as low back pain, neck pain or osteoarthritis is recognised as one of the leading causes of disability worldwide1, resulting in increased healthcare expenditure and longer waiting times for orthopaedic and rheumatology outpatient services2,3. Adult orthopaedic services represent the largest waiting list in Ireland (June 2023) with a total of 64,867. Up to 25% of patients are waiting more than 12 months for orthopaedic (22%) and rheumatology (25%) appointments in secondary care4.
In 2011, to reduce outpatient Orthopaedic and Rheumatology waiting times in Ireland, the Health Service Executive (HSE) National Clinical Programmes for Trauma and Orthopaedics (NCPTOS), and Rheumatology (NCPR) established the National MSK Triage Initiative, consisting of 24 clinical specialist physiotherapist (CSP) posts in 18 acute Hospital sites nationwide. In these MSK Triage clinics, CSPs triage patients on outpatient orthopaedic and rheumatology waiting lists, who are unlikely to require consultant care, onto appropriate care pathways. In a national audit, over 80% of patients presenting to MSK-triage clinics in Ireland were managed independently by the CSP, with 71% discharged at their initial appointment5 and 23% referred to physiotherapy6. From 2012 to 2018, 125,852 patients on orthopaedic and rheumatology waiting lists were managed through MSK triage services7. Access to primary care physiotherapy also presents a barrier to patients, with 56,200 on primary care waiting lists and 22% (12,502) waiting greater than one year to access primary care physiotherapy services in 20228. Longer waiting times to access physiotherapy can negatively affect patients’ quality of life, psychological wellbeing, healthcare utilisation, health outcomes and economics3,9,10.
Several predictors of pain and functional outcomes in MSK conditions across primary and community care settings have previously been identified, including baseline function, pain intensity, mental well-being, co-morbidities, age, body mass index (BMI), duration of symptoms, work status, education level11, health literacy12, and altered pain processing13; which can also predict non-response to physiotherapy14. Recently, MSK core outcome sets, and prognostic stratification tools (such as the Subgroups for Targeted Treatment Back (STarT Back) and Subgroups for Targeted Treatment MSK (STarT MSK)), have been developed, based on established prognostic factors11,15, and validated to identify earlier, those at risk of developing persistent MSK pain16,17.
Whilst the National MSK Triage Initiative has been successful in reducing acute hospital outpatient orthopaedic and rheumatology waiting lists, the high discharge rate of 71% at initial appointment5 warrants further examination to explore the patient journey and potential reasons why patients are not referred to the right service at the right time, in line with the Irish government health reform plan (Sláintecare)18. It is possible that suboptimal access to primary care services, may be influencing referrer behaviour and decision making. Research to date has shown that MSK triage is an effective waiting list initiative with good service user and healthcare professional satisfaction5,7,19–22. However, currently, patient outcomes, prognostic stratification, and predictors of outcome up to 1-year later have not been consistently studied in patients attending MSK triage clinics, who do not require consultant-led orthopaedic or rheumatology care, in Ireland or internationally. Therefore, we wanted to explore the cohort of patients attending secondary care MSK triage who do not require surgical or medical input from the orthopaedic surgeon or rheumatologist to better understand their healthcare journey (healthcare utilisation), clinical outcomes (pain and function) and predictors of clinical outcome.
The primary aim of this prospective, cohort study is to identify predictors of clinical outcome (pain and function) at 12-months post MSK-triage appointment.
Secondary aims are to:
1. Describe the clinical course of patients attending MSK triage clinics, on the outcomes of pain intensity, function, work status and MSK health status, at 3 months (short-term), 6 months (medium-term) and 12 months (long-term).
2. Measure self-reported use of healthcare resources over the 12-month follow-up period post-MSK-triage appointment.
ADAPT MSK is a prospective, observational, cohort study. The STROBE standardised reporting guidelines will be used to guide the reporting of this study23. Adults with MSK pain attending CSP-led MSK triage clinics will be recruited from five sites across Ireland. Baseline assessment will consist of baseline demographics, work status, healthcare utilisation and self-report questionnaires on pain, function, MSK health status, fear of movement, anxiety and depression and baseline clinical factors (e.g. number of MSK pain sites, co-morbidities and health literacy) (Table 1). Follow-up at 3, 6 and 12 months will involve repeat measurement of work status, healthcare utilisation and self-report questionnaires.
Ethical approval for this study was granted by the Research Ethics Committees in Beaumont Hospital (Ref: 22/34), Tallaght University Hospital (Ref: 2418), Merlin Park Hospital (Ref: C.A. 2870), Midlands Regional Hospital Tullamore (Ref: RRECB1022FC) and St Vincent’s University Hospital (Ref: RS23-010). Written informed consent will be obtained from eligible participants prior to study recruitment, in line with the Data Protection Act 2018 (Section 36(2))24.
This study will be based in MSK Triage clinics across five urban and regional secondary care sites in Ireland. These clinics are run by CSPs with more than five years clinical experience and the majority achieving a postgraduate MSc or PhD degree, in the field of MSK physiotherapy5. They provide expert assessment, diagnosis and education to patients and identify the most appropriate management pathway for patients with MSK disorders. The typical journey for patients attending these clinics (Figure 1) involves an initial referral from the patient’s GP to secondary care orthopaedics or rheumatology. The consultant in secondary care then triages this referral to the MSK triage clinic or the consultant-led clinic. Patients deemed unlikely to require orthopaedic surgeon or rheumatology consultant care are triaged to these MSK triage clinics, which aims to improve service efficiency by reducing secondary care waiting lists and directing patients towards the appropriate service for their needs7.
A consecutive sample of patients presenting to orthopaedic and rheumatology MSK-triage clinics with MSK pain will be recruited. Participants will be eligible if they are aged 18 years or over, are triaged for non-consultant care at one of the five participating MSK triage services across Ireland and have sufficient English language proficiency for the completion of self-reported questionnaires.
Patients will be ineligible to participate if they’ve been triaged by the CSP for orthopaedic surgical or rheumatologist assessment, are unable to communicate in English (written and spoken word), along with those who present with clinical indicators of suspected ‘red flag’ pathology (e.g. recent trauma with significant injury; acute, red, hot, or swollen joints; suspected fracture; joint infection; cancer)27; or a diagnosed systemic inflammatory MSK condition (such as rheumatoid arthritis) or a diagnosis of dementia or terminal illness.
The estimated sample size is based on the primary study aim ‘to identify predictors of clinical outcome (pain and function) at 12-months post MSK-triage appointment’. Sample size is determined based on including 18 predictor variables in univariate analysis and with 10 events required per predictor variable28, a sample of 180 participants is required. To allow for a 40% drop-out at the 12-month follow-up, an additional 72 participants were added, resulting in a final sample size estimate of 252 participants.
The MSK triage physiotherapist will identify and screen prospective participants for eligibility following their MSK triage appointment. If eligible, they will provide a participant information leaflet, briefly explain the aims of the study, and obtain written consent to be contacted by the primary investigator (FC). This allows the primary investigator to contact prospective participants to answer any questions about the study and if interested in participating, obtain informed written or electronic consent.
Once recruited, each participant will undergo a baseline assessment with the primary investigator, capturing participant demographics and healthcare utilisation, via Microsoft Teams or telephone, depending on participant preference. Thereafter, participants will complete a number of self-report questionnaires based on established prognostic factors i.e., baseline function, pain intensity, mental wellbeing, symptom duration, fear avoidance/catastrophising, quality of life/self-efficacy, widespread pain, age, co-morbidities, work absence duration, and education level15,29,30. This data will be collected through Research Electronic Data capture (REDCap) software31,32, hosted at RCSI, on their personal device, or via posted paper questionnaires, to facilitate participants with limited information technology skills.
Demographic information will include participant gender, age, level of education, presenting MSK complaint, duration of symptoms, number of MSK pain sites, previous physiotherapy/surgery for presenting complaint, and work status (work absence, work classification and work absence duration). Co-morbidities will be identified from a list of 12 comorbid conditions, informed by the National Institute of Clinical Excellence (NICE) indicator for multi-morbidity in primary care33. Health literacy will be explored using the single-item literacy screener34. Healthcare utilisation will be recorded using a modified version of the Managing of OSteoArthritis In ConsultationS (MOSAICS) trial questionnaire35, which captures advice and information received about their condition, self-management, prescribed medications, aids and appliances, private/public health services (e.g., physiotherapy, GP, nursing, occupational therapy, podiatry), treatments, and investigations.
Self-report questionnaires will include the Musculoskeletal Health Questionnaire (MSK-HQ)36, STarT MSK tool17, and Patient Specific Functional Scale (PSFS)37 to assess functional and MSK health status; pain intensity through the Numerical Pain Rating Scale (NPRS)38,39; fear of movement through the 11-item Tampa Scale for Kinesiophobia40 and psychological distress via the Hospital Anxiety and Depression scale (HADS)41.
All participants recruited in two sites (Beaumont Hospital and Tallaght University Hospital) will be invited to participate in a once-off baseline physical examination, consisting of grip strength examination, neurological exam, and quantitative sensory testing (Table 1).
Pain hypersensitivity, measured by quantitative sensory testing, has been shown to be a predictor of worse outcome (pain and disability) at follow-up across multiple MSK conditions (e.g., osteoarthritis, low back pain, whiplash, post-operative pain) and different body sites (e.g., hip, knee, low back, shoulder and neck)13. Quantitative sensory testing uses standardised testing protocols of somatosensory nerve function, to investigate potential underlying pain mechanisms42,43. The International Association for the Study of Pain (IASP) task force clinical criteria and grading system for nociplastic pain involves a stepwise approach to differentiate between predominant nociceptive, neuropathic or nociplastic pain25, which, in conjunction with the NeuPSIG guidelines on neuropathic assessment26 will be used to categorise participants’ dominant pain phenotype (Figure 1). A quantitative sensory testing protocol including pressure pain thresholds (PPT), dynamic mechanical allodynia, pinprick, temporal summation and cold pain thresholds will be used to assess pain sensitivity in accordance with IASP and NeuPSIG grading systems25,26.
Grip strength is regarded as a biomarker of current health status and has been adopted as a singular indicator of overall body strength44–46. Grip strength will be assessed isometrically using a calibrated Jamar Plus Digital dynamometer following a standard protocol47.
The primary investigator will contact participants at three, six, and 12 months via Microsoft Teams or telephone to collect healthcare utilisation data and work status (work absence, work classification and work absence duration). Self-report questionnaires (MSK-HQ, STarT MSK, Patient Specific Functional scale, and NPRS) will be sent electronically via REDCap software or via post. Any participant withdrawals or loss to follow-up will be recorded.
The primary outcomes of interest are pain intensity (NPRS) and function (PSFS). Secondary outcomes are musculoskeletal risk stratification status (STarT MSK), musculoskeletal health (MSK-HQ), healthcare utilisation and work status (work classification, work absence and work absence duration).
Statistical methods will follow the STROBE guidelines23 and the TRIPOD consensus statement for transparent reporting of a multivariable prediction model for individual prognosis and/or diagnosis for transparent reporting of a multivariable prediction model for individual prognosis and/or diagnosis48. Descriptive statistics will be used to profile the characteristics of the cohort at baseline, three, six, and 12 months. Multivariable linear regression will be used to identify baseline predictors of pain and function outcomes at the primary timepoint of 12 months following MSK triage appointment. Models will be adjusted for potential confounding factors, checking for interactions and collinearity. The extent of missing data will be assessed and reported, and the mechanism causing the missing data explored. Multiple imputation will be used if the conditions support its use and a sensitivity analysis conducted with complete case data. Variables included in the multivariable regression model will be selected if deemed clinically significant, or if they have a univariable p-value of <0.2. Statistical significance will be inferred when the pvalue is <0.05. Stata 18 statistical software (StataCorp, College Station, Tx, USA) will be used for statistical analyses.
Findings from this study will be disseminated via peer-reviewed journal publication and presentation at national and international conferences. Engagement with a public patient involvement (PPI) panel will explore dissemination strategies for public and service user engagement.
Data collection commenced in December 2022, with study completion anticipated in January 2025.
The burden of MSK disorders is increasing exponentially worldwide, resulting in significant pressure on healthcare systems. People with MSK pain who present to their GP in Ireland are faced with difficulties accessing first-line public services, such as primary care physiotherapy and subsequently specialised orthopaedic and rheumatology services. To address secondary care waiting lists and improve service efficiency, the National MSK Triage Initiative, MSK triage clinics, run by CSPs under the clinical governance of Orthopaedic and Rheumatology Consultants commenced in Ireland in 2011, and has demonstrated success as a waiting list initiative. However, high discharge rates and onward referral to primary care physiotherapy following MSK triage suggest that these patients may have been managed more appropriately in primary care if sufficiently resourced. Currently, the patient journey and long-term outcomes following their MSK triage attendance are unknown. This longitudinal cohort study aims to identify predictors of pain and function outcomes up to 1 year following MSK triage attendance; measure individuals’ self-reported use of healthcare resources and explore MSK phenotypes based on identified prognostic factors. Identifying predictors of outcome (pain and function) at 12 months has the potential to inform decision making on the optimal patient pathway and trajectory of care by enabling the identification of those at risk of a poor outcome at 1 year, earlier in their journey. This research has the potential to inform future needs within primary care for those with MSK conditions, as well as the implementation of pathways from primary to secondary care orthopaedics and rheumatology, ensuring that patients receive the ‘right care, at the right place, at the right time’ in line with SláinteCare principles18.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Rehabilitation, Osteoarthritis, Musculoskeletal Research, Ergonomics, Physical Fatigue
Is the rationale for, and objectives of, the study clearly described?
Partly
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: musculoskeletal pain, knee pain
Is the rationale for, and objectives of, the study clearly described?
Partly
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Physiotherapist led orthopaedic triage. Have not focused on the statistics part as that is not my area of expertise.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Biostatist
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||||
---|---|---|---|---|
1 | 2 | 3 | 4 | |
Version 2 (revision) 23 Jan 25 |
read | |||
Version 1 06 Dec 23 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)